Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04222101 · ClinicalTrials.gov registry record · NA
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
A NA study, sponsored by Le Bonheur Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04222101 is a NA study that was terminated before completion, run by Le Bonheur Children's Hospital. The registered enrollment target is 9 participants.
The verdict
NCT04222101, a NA study, was terminated before completion, sponsored by Le Bonheur Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will investigate whether there is an association between insulin resistance and cardiac function in children with dilated or hypertrophic cardiomyopathy. This study will also investigate whether there is an association between FGF21 and cardiac function in children with dilated or hypertrophic cardiomyopathy and whether this is mediated through greater insulin resistance and/or through independent effects.
Interventions
- DIAGNOSTIC_TEST Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-10-07 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04222101
The ClinicalTrials.gov registry entry for NCT04222101 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Le Bonheur Children's Hospital, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.
NCT04222101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04222101 about?
NCT04222101 is a clinical study titled "Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy". This study will investigate whether there is an association between insulin resistance and cardiac function in children with dilated or hypertrophic cardiomyopathy. This study will also investigate whether there is an association between FGF21 and cardiac function in children with dilated or hypertr...
What is the current status of trial NCT04222101?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2019-10-07. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04222101?
The interventions under investigation include: Oral glucose tolerance test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04222101?
This trial is sponsored by Le Bonheur Children's Hospital, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.